Effect of memantine in treatment of dyslexia
Phase 2
- Conditions
- dyslexia.Dyslexia and other symbolic dysfunctions, not elsewhere classified
- Registration Number
- IRCT2016091329807N1
- Lead Sponsor
- Isfahan University of Medical Sciences, Faculty of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 62
Inclusion Criteria
Age <14 years; diagnosis of dyslexia with standard test; acceptance of parcipitating in study; no any disease in which memantine is contraindicated; no any disease such as ADHD, mental retardation, stuttering and ect.
Exclusion criteria:
Not wanting to continue participating in the project; having special disease; the incidence of side effects related to medication.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ama dyslexia test score. Timepoint: Before the study, the first month, third month. Method of measurement: Nama dyslexia test that evaluated by the psychologist.
- Secondary Outcome Measures
Name Time Method Don't have. Timepoint: not calculated. Method of measurement: not calculated.